Published in Biochem Pharmacol on April 01, 1968
Effect of a synthetic analogue of vasopressin in animals and in patients with diabetes insipidus. Lancet (1968) 2.24
5-Azacytidine, a new, highly effective cancerostatic. Experientia (1964) 1.84
Covalent structure of bovine trypsinogen. The position of the remaining amides. Biochem Biophys Res Commun (1966) 1.58
Acyclic nucleotide analogues: synthesis, antiviral activity and inhibitory effects on some cellular and virus-encoded enzymes in vitro. Antiviral Res (1990) 1.57
Biological effects of 5-azacytidine in eukaryotes. Oncology (1974) 1.54
Cytokinin-derived cyclin-dependent kinase inhibitors: synthesis and cdc2 inhibitory activity of olomoucine and related compounds. J Med Chem (1997) 1.28
Synthetic analogues of oxytocin acting as hormonogens. Br J Pharmacol Chemother (1966) 1.14
L-ribonucleosides do not penetrate bacterial cell walls. FEBS Lett (1971) 1.11
Incorporation of 5-azacytidine into nucleic acids of Escherichia coli. Biochim Biophys Acta (1968) 1.05
The action of 5-azacytidine on bacteria infected with bacteriophage T4. Biochim Biophys Acta (1967) 1.02
The structure of DNA from Escherichia coli cultured in the presence of 5-azacytidine. Biochim Biophys Acta (1965) 1.02
Incorporation of a potent antileukemic agent, 5-aza-2'-deoxycytidine, into DNA of cells from leukemic mice. Cancer Res (1977) 1.01
Serine-containing active center of alkaline proteinase of Aspergillus flavus. Biochim Biophys Acta (1969) 1.00
Covalent structure of bovine chymotrypsinogen A. Biochim Biophys Acta (1966) 0.97
Amino acid sequence of C-terminal fragment of hog pepsin. Eur J Biochem (1970) 0.96
Effect of 5-aza-2'-deoxycytidine against leukemic and hemopoietic tissues in AKR mice. Neoplasma (1968) 0.96
Azapyrimidine nucleosides: metabolism and inhibitory mechanisms. Adv Enzyme Regul (1985) 0.93
Characteristics of mouse leukemic cells resistant to 5-azacytidine and 5-aza-2'-deoxycytidine. Cancer Res (1968) 0.93
Mode of action and effects of 5-azacytidine and of its derivatives in eukaryotic cells. Pharmacol Ther (1985) 0.92
Synthesis of showdomycin. Tetrahedron Lett (1970) 0.91
The effects of 5-azacytidine and 5-azauridine on protein synthesis in Escherichia coli. Biochem Biophys Res Commun (1970) 0.90
Association of decreased uridine and deoxycytidine kinase with enhanced RNA and DNA polymerase in mouse leukemic cells resistant to 5-azacytidine and 5-aza-2'-deoxycytidine. Cancer Res (1970) 0.88
Prolongation of the lag period preceding the enhancement of thymidine and thymidylate kinase activity in regenerating rat liver by 5-azacytidine. Biochem Pharmacol (1972) 0.87
Resonance properties of the vocal folds: in vivo laryngoscopic investigation of the externally excited laryngeal vibrations. J Acoust Soc Am (2000) 0.86
Inhibition of protein synthesis by 5-azacytidine in Escherichia coli. Biochim Biophys Acta (1967) 0.86
Phosphorylation of acyclic nucleotide analogs HPMPA and PMEA in L1210 mouse leukemia cell extracts. Neoplasma (1990) 0.86
Characterization of polyribosomes and maturation of ribosomal RNA in hepatoma cells treated with 5-azacytidine. Cancer Res (1974) 0.85
Constitution of a compound with a pronounced juvenile hormone activity. Proc Natl Acad Sci U S A (1967) 0.85
Enhanced stability of uridine kinase from mouse leukemic cells resistant to 5-azacytidine. Thermal inactivation and effect of p-chloromercuribenzoate. Eur J Biochem (1971) 0.84
Decreased synthesis of DNA in regenerating rat liver after the administration of reserpine. Br J Pharmacol (1973) 0.84
Biochemical mechanisms of drug resistance. IV. Development of resistance to 5-azacytidine and simultaneous depression of pyrimidine metabolism in leukemic mice. Int J Cancer (1967) 0.84
Synthesis of DNA in the liver and testes of cadmium-tested partially hepatectomized rats. J Biochem (1979) 0.83
Studies on the active site of trypsin. II. The role of the imidazole ring of histidine in the catalytic action of trypsin. Biochem Biophys Res Commun (1965) 0.83
Incorporation of 5-azacytidine into liver ribonucleic acids of leukemic mice sensitive and resistant to 5-azacytidine. Biochim Biophys Acta (1965) 0.82
Nitration of tyrosine residues in the pancreatic trypsin inhibitor with tetranitromethane. Eur J Biochem (1968) 0.82
The effect of blood around a flap pedicle on flap perfusion in an experimental rodent model. Acta Chir Plast (2009) 0.82
The mode of action of 5-aza-2'-deoxycytidine in Escherichia coli. Eur J Biochem (1970) 0.81
Synergistic effect of cis-dichlorodiammineplatinum and 5-aza-2'-deoxycytidine on mouse leukemic cells in vivo and in vitro. Int J Cancer (1982) 0.81
Loss of coding properties of the trinucleotide guanylyl-uridylyl-uridine on replacement of uridylic by dihydrouridylic acid. Biochim Biophys Acta (1966) 0.80
Effects of 5-azacytidine on hepatic polyribosomes and maturation of ribosomal RNA. Acta Biol Med Ger (1974) 0.80
Enzymes relevant to cancer chemotherapy II. Heterogeneity of rat kidney uridine kinase following chromatography on Sepharose 6B coupled to N4-(5-amino-Pentyl)-cytidine. Neoplasma (1977) 0.80
Cleft palate repair by Furlow double-reversing Z-plasty: first speech results at the age of 6 years. Acta Chir Plast (2000) 0.80
Synthetic cyclin dependent kinase inhibitors. New generation of potent anti-cancer drugs. Adv Exp Med Biol (1999) 0.80
Enhanced uridine kinase in rat liver following 5-azacytidine administration. In vivo characterization and properties of partially purified enzyme. J Biol Chem (1973) 0.80
Effect of 5'-substitution on the template activity of oligo-nucleotides for the binding of valine and alanine tRNA to ribosomes. Biochim Biophys Acta (1970) 0.79
History of upper extremity replantation in the Czech Republic and worldwide. Acta Chir Plast (2004) 0.79
Uridine kinase: properties, biological significance and chemotherapeutic aspects (a review). Neoplasma (1976) 0.79
N-Terminal fragment of hog pepsin. Eur J Biochem (1969) 0.79
Effect of 5'-terminal phosphate on the recognition of some dinucleoside phosphates by [14C]aminoacyl-tRNA. Biochim Biophys Acta (1968) 0.79
Large scale isolation, characterization and classification of pig immunoglobulin kappa-chains. Eur J Biochem (1970) 0.78
Effect of 5-azacytidine and 6-azauridine on the synthesis of DNA in embryonic mouse brain mitotic activity and migration of ventricular cells. Neoplasma (1973) 0.78
Different anticodons in purified valine tRNA fractions from yeast. Biochim Biophys Acta (1968) 0.78
Cell suspensions, cell cultures, and tissue slices--important metabolic in vitro systems. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub (2001) 0.78
Partial reversal of toxic effects of 5-azacytidine by 6-azauridine in normal mice. Experientia (1965) 0.78
5-azacytidine in childhood leukemia. Neoplasma (1971) 0.78
Effects of the alpha-D-anomer of 5-aza-2'-deoxycytidine on L1210 mouse leukemic cells in vitro and in vivo. Cancer Res (1984) 0.78
Table of amino acid replacements in proteins possible as a result of one-point mutations. Int J Pept Protein Res (1977) 0.78
Synergistic action of 5-aza-2'-deoxycytidine and 3-deazauridine on L1210 leukemic cells and EMT6 tumor cells. Cancer Res (1979) 0.78
Resistance of mammalian tumour cells toward pyrimidine analogues. A review. Oncology (1973) 0.77
Tumor necrosis factor alpha in various tissues of insulin-resistant obese Koletsky rats: relations to insulin receptor characteristics. Physiol Res (1999) 0.77
[Treatment of congenital pseudarthrosis of tibia by vascularized fibular graft]. Acta Chir Orthop Traumatol Cech (2006) 0.77
Preparation and biological activity of 5,6-dihydro-5-azapyrimidine nucleosides. Nucleic Acids Symp Ser (1987) 0.77
Impaired gastric secretion in rats treated with 5-azacytidine. Arch Int Pharmacodyn Ther (1974) 0.77
In vivo metabolism of 2,6,9-trisubstituted purine-derived cyclin-dependent kinase inhibitor bohemine in mice: glucosidation as the principal metabolic route. Drug Metab Dispos (2001) 0.77
The determination of 5-azapyrimidines and their derivatives in bacterial RNA. FEBS Lett (1971) 0.77
Effect of 5-azacytidine on developing mouse embryo. Experientia (1968) 0.77
Inhibitory effect of various cytostatics and cycloheximide on acute experimental pancreatitis in rats. Gut (1977) 0.77
The use of medicinal leeches in fingertip replantation without venous anastomosis - case report of a 4-year-old patient. Acta Chir Plast (2014) 0.77
5-Aza-2'-deoxycytidine: preclinical studies in mice. Neoplasma (1980) 0.77
Enhanced DNA-dependent RNA polymerase and RNA synthesis in rat liver nuclei after administration of L-tryptophan. Biochim Biophys Acta (1970) 0.77
Inactivation of deamino-oxytocin, deamino-carba-oxytocin, (D-lys)-, and (D-arg)vasopressins by kidney cell particles. Experientia (1969) 0.77
Metabolic transformations of 5-azaorotate: cause of marked inhibition of orotidine-5'-phosphate decarboxylase. Biochim Biophys Acta (1967) 0.77
Metabolic alterations of liver regeneration. 8. Enhanced synthesis of DNA in the liver of 5-azacytidine-treated rats subjected to partial hepatectomy. Int J Cancer (1972) 0.77
[Sjogren's syndrome with paraproteinemia and hyperglobulinemic purpura]. Vnitr Lek (1967) 0.77
[Surgical treatment of endocrine orbital disease. Indications, methods,results]. Vnitr Lek (1992) 0.76
[Immunomodulation of recurrent urinary tract infections with Urvakol vaccine]. Bratisl Lek Listy (1999) 0.76
[Possibilities for the clinical use of 5-azacytidine]. Vopr Onkol (1977) 0.76